1. H. Aihara, J. Miyaziki, 1998 Gene transfer into muscle by electroporation in vivo, Nat Biotechnol, 16 9 (September 1998), 867 870

  2. V. R. Arruda, H. H. Stedman, V. Haurigot, G. Buchlis, S. Baila, P. Favaro, Y. Chen, H. G. Franck, S. Zhou, J. F. Wright, L. B. Couto, H. Jiang, G. F. Pierce, D. A. Bellinger, F. Mingozzi, T. C. Nichols, K. A. High, 2010 Peripheral transvenular delivery of deno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B, Blood, 115 23 (June 2010), 4678 4688

  3. M. B. Atkins, M. J. Robertson, M. Gordon, M. T. Lotze, M. De Coste, Bois. J. S. Du, J. Ritz, A. B. Sandler, H. D. Edington, P. D. Garzone, J. W. Mier, C. M. Canning, L. Battiato, H. Tahara, M. L. Sherman, 1997 Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies, Clin Cancer Res., 3 3 (March 1997), 409 417

  4. G. B. Banks, J. S. Chamberlain, 2008 The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies, Curr Top Dev Biol, 84 431 453

  5. P. J. Bergman, J. Mc Knight, A. Novosad, S. Charney, J. Farrelly, D. Craft, M. Wulderk, Y. Jeffers, M. Sadelain, A. E. Hohenhaus, N. Segal, P. Gregor, M. Engelhorn, I. Riviere, A. N. Houghton, J. D. Wolchok, 2003 Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial, Clin Cancer Res, 9 4 (April 2003), 1284 1290

  6. A. M. Bodles-Brakhop, P. A. Brown, M. A. Pope, R. Draghia-Akli, 2008 Double-blinded, Placebo-controlled plasmid GHRH trial for cancer-associated anemia in dogs, Mol Ther, 16 5 (May 2008), 862 870

  7. P. A. Brown, A. Bodles-Brakhop, R. Draghia-Akli, 2008 Plasmid growth hormone releasing hormone therapy in healthy and laminitis-afflicted horses-evaluation and pilot study, J Gene Med, 10 5 (May 2008), 564 574

  8. P. A. Brown, A. M. Bodles-Brakhop, M. A. Pope, R. Draghia-Akli, 2009 Gene therapy by electroporation for the treatment of chronic renal failure in companion animals, BMC Biotechnol, (January 2009), 9:4 EOF

  9. M. J. Brunda, L. Luistro, R. R. Warrier, et al. 1993 Antitumor and antimetastatic activity of interleukin 12 against murine tumors, J Exp Med, 178 4 (October 1993), 1223 1230

  10. V. Budker, T. Budker, G. Zhang, V. Subbotin, A. Loomis, J. A. Wolff, 2000 Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process, J Gene Med, 2 2 (March 2000), 76 88

  11. M. Buettner, G. Belke-Louis, H. J. Rziha, C. Mc Innes, O. R. Kaaden, 1998 Detection, cDNA cloning and sequencing of canine interleukin 12, Cytokine, 10 4 (April 1998), 241 248

  12. B. D. Car, V. M. Eng, J. M. Lipman, T. D. Anderson, 1999 The toxicology of interleukin-12: a review. Toxicol Pathol, 27 1 (January 1999), 58 63 .

  13. M. Cemazar, G. Sersa, 2007 Electrotransfer of therapeutic molecules into tissues. Curr Opin Mol Ther, 9 6 (December 2007), 554 562

  14. M. Cemazar, Y. Tamzali, G. Sersa, N. Tozon, L. M. Mir, D. Miklavcic, R. Lowe, J. Teissie, 2008 Electrochemotherapy in veterinary oncology, J Vet Intern Med, 22 4 (July 2008), 826 831

  15. M. Cemazar, T. Jarm, G. Sersa, Cancer electrogene therapy with interleukin-12, Curr Gene Ther, 10 10 4 300 311

  16. J. Cutrera, M. Torrero, K. Shiomitsu, N. Mauldin, S. Li, 2008 Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs, Methods Mol Biol, 423 319 325

  17. A. I. Daud, R. C. De Conti, S. Andrews, P. Urbas, A. I. Riker, V. K. Sondak, P. N. Munster, D. M. Sullivan, K. E. Ugen, J. L. Messina, R. Heller, 2008 Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma J Clin Oncol, 26 36 (December 2008), 5896 5903

  18. J. A. Dixon, F. G. Spinale, 2009 Large animal models of heart failure: a critical link in he translation of basic science to clinical practice, Circ Heart Fail, 2 3 (May 2009), 262 271

  19. S. Dow, R. Elmslie, I. Kurzman, Ewen. G. Mac, F. Pericle, D. Liggitt, 2005 Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases, Hum Gene Ther, 16 8 (August 2005), 937 946

  20. R. Draghia-Akli, K. A. Hahn, G. K. King, K. K. Cummings, R. H. Carpenter, 2002 Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer, Mol Ther, 6 6 (December 2002), 830 836

  21. J. G. Fewell, Laughlin. F. Mac, V. Mehta, M. Gondo, F. Nicol, E. Wilson, L. C. Smith, 2001 Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation, Mol Ther, 3 4 (April 2001), 574 583

  22. L. E. Fox, 2002 Mast Cell Tumors. In: Cancer in dogs and cats: medical and surgical management, 2nd ed., Morrison, W.B., ed., 451 460 , Teton NewMedia, Jackson Hole, 1-89344-147-4

  23. A. K. Fulmer, G. E. Mauldin, 2007 Canine histiocytic neoplasia: An overview, Can Vet J, 48 10 (October 2007), 1046 1050

  24. J. Gehl, T. H. Sorensen, K. Nielsen, P. Raskmark, S. L. Nielsen, T. Skovsgaard, L. M. Mir, 1999 In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution, Biochim Biophys Acta, 1428 2-3 , (August 1999), 233 240

  25. R. Gravier, D. Dory, M. Laurentie, S. Bougeard, R. Cariolet, A. Jestin, 2007 In vivo tissue distribution and kinetics of a pseudorabies virus plasmid DNA vaccine after intramuscular injection in swine, Vaccine, 25 39-40 , (September 2007), 6930 6938

  26. E. Hanna, X. Zhang, J. Woodlis, R. Breau, J. Suen, S. Li, 2001 Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site, Cancer Gene Ther, 8 3 (March 2001), 151 157

  27. N. C. Hasbrouck, K. A. High, 2008 AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects, Gene Ther, 15 11 (June 2008), 870 875

  28. V. Haurigot, F. Mingozzi, G. Buchlis, D. J. Hui, Y. Chen, E. Basner-Tschakarjan, V. R. Arruda, A. Radu, H. G. Franck, J. F. Wright, S. Zhou, H. H. Stedman, D. A. Bellinger, T. C. Nichols, K. A. High, 2010 Safety of AAV factor IX peripheral transvenular gene elivery to muscle in hemophilia B dogs, Mol Ther, 18 7 (July 2010), 1318 1329

  29. L. M. Heinzerling, K. Feige, S. Rieder, M. K. Akens, R. Dummer, G. Stranzinger, K. Moelling, 2001 Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses, J Mol Med, 78 12 692 702

  30. L. C. Heller, K. Merkler, J. Westover, Y. Cruz, D. Coppola, K. Benson, A. Daud, R. Heller, 2006 Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model, Clin Cancer Res, 12 10 (May 2006), 3177 3183

  31. L. C. Heller, R. Heller, 2010 Electroporation gene therapy preclinical and clinical trials for melanoma, Curr Gene Ther, 10 4 (August 2010), 312 317

  32. R. W. Herzog, J. D. Mount, V. R. Arruda, K. A. High, C. D. Lothrop, Jr , 2001 Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation, Mol Ther, 4 3 , (September 2001), 192 200

  33. J. M. Howell, K. R. Walker, L. Davies, E. Dunton, A. Everaardt, N. Laing, G. Karpati, 2008 Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle’s disease: expression and re-expression of glycogen phosphorylase, Neuromuscul Disord, 18 3 (March 2008), 248 258

  34. C. Hüttinger, J. Hirschberger, A. Jahnke, R. Köstlin, T. Brill, C. Plank, H. Küchenhoff, S. Krieger, U. Schillinger, 2008 Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial, J Gene Med, 10 6 (June 2008), 655 667

  35. A. Jahnke, J. Hirschberger, C. Fischer, T. Brill, R. Köstlin, C. Plank, H. Küchenhoff, S. Krieger, K. Kamenica, U. Schillinger, 2007 Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study, J Vet Med A Physiol Pathol Clin Med, 54 10 (December 2007), 599 606

  36. U. Kamensek, G. Sersa, 2008 Targeted gene therapy in radiotherapy, Radiol Oncol, 42 3 115 135

  37. D. Kamstock, A. Guth, R. Elmslie, I. Kurzman, D. Liggitt, L. Coro, J. Fairman, S. Dow, 2006 Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma, Cancer Gene Ther, 13 3 (March 2006), 306 317

  38. M. G. Katz, J. D. Swain, J. D. White, D. Low, H. Stedman, C. R. Bridges, 2010 Cardiac gene therapy: optimization of gene delivery techniques in vivo, Hum Gene Ther, 21 4 (April 2010), 371 380

  39. A. S. Khan, L. C. Smith, R. V. Abruzzese, K. K. Cummings, M. A. Pope, P. A. Brown, R. Draghia-Akli, 2003 Optimization of of electroporation parameters for the intramuscular delivery of plasmids in pigs. DNA Cell Biol, 22 12 (December 2003), 807 814

  40. M. Kobayashi, L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, G. Trinchieri, 1989 Identification and purification of natural-killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human-lymphocytes, J Exp Med, 170 3 (September 1989), 827 845

  41. V. Kodre, M. Cemazar, J. Pecar, G. Sersa, A. Cor, N. Tozon, 2009 Electrochemotherapy compared to surgery for treatment of canine mast cell tumours, In Vivo, 23 1 (January 2009), 55 62

  42. J. N. Kornegay, J. Li, J. R. Bogan, D. J. Bogan, C. Chen, H. Zheng, B. Wang, C. Qiao, J. F. Howard, Jr , X. Xiao, 2010 Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs, Mol Ther, 18 8 (August 2010), 1501 1508

  43. O. Kristal, K. M. Rassnick, J. M. Gliatto, N. C. Northrup, J. D. Chretin, K. Morrison-Collister, S. M. Cotter, A. S. Moore, 2004 Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs, J Vet Intern Med, 18 1 (January 2004), 75 80

  44. S. C. Lee, C. J. Wu, P. Y. Wu, Y. L. Huang, C. W. Wu, M. H. Tao, 2003 Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene, J Biomed Sci, 10 1 (January 2003), 73 86

  45. J. P. Leonard, M. L. Sherman, G. L. Fisher, L. J. Buchanan, G. Larsen, M. B. Atkins, J. A. Sosman, J. P. Dutcher, N. J. Vogelzang, J. L. Ryan, 1997 Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production, Blood, 90 7 (October 1997), 2541 2548

  46. S. Li, L. Zhang, M. Torrero, M. Cannon, R. Barret, 2005 Administration route- and immune cell activation-dependant tumor eradication by IL-12 electrotransfer, Mol Ther, 12 5 (November 2005), 942 949

  47. Q. Lu, G. Bou-Gharion, T. A. Partridge, 2003 Non-viral gene delivery in skeletal muscle: a protein factory, Gene Ther, 10 2 (January 2003), 131 142

  48. M. L. Lucas, L. Heller, D. Coppola, R. Heller, 2002 IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma, Mol Ther, 5 6 (June 2002), 668 675

  49. M. L. Lucas, R. Heller, 2003 IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma, DNA and Cell Biol, 22 12 (December 2003), 755 763

  50. D. L. Mc Caw, M. A. Miller, P. J. Bergman, S. J. Withrow, A. S. Moore, D. W. Knapp, D. Fowler, J. C. Johnson, 1997 Vincristine therapy for mast cell tumors in dogs, J Vet Intern Med, 11 6 (November 1997), 375 378

  51. A. Mena, M. E. Andrew, B. E. Coupar, 2001 Rapid dissemination of intramuscularly inoculated DNA vaccines, Immunol Cell Biol, 79 1 (February 2001), 87 89

  52. L. M. Mir, L. F. Glass, G. Sersa, J. Teissié, C. Domenge, D. Miklavcic, M. J. Jaroszeski, S. Orlowski, D. S. Reintgen, Z. Rudolf, M. Belehradek, R. Gilbert, M. P. Rols, J. Belehradek, Jr , J. M. Bachaud, R. De Conti, B. Stabuc, M. Cemazar, P. Coninx, R. Heller, 1998 Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy, Br J Cancer, 77 12 (June 1998), 2336 2342

  53. L. M. Mir, M. F. Bureau, J. Gehl, R. Rangara, D. Rouy, J. M. Caillaud, P. Delaere, D. Branellec, B. Schwartz, D. Scherman, 1999 High-efficiency gene transfer into skeletal muscle mediated by electric pulses, Proc Natl Acad Sci U S A, 96 8 (April 1999), 4262 4267

  54. R. J. Motzer, A. Rakhit, L. H. Schwartz, T. Olencki, T. M. Malone, K. Sandstrom, R. Nadeau, H. Parmar, R. Bukowski, 1998 Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma, Clin Cancer Res, 4 5 (May 1998), 1183 1191

  55. C. L. Nastala, H. D. Edington, T. G. Mc Kinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, 1994 Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production, J Immunol, 153 4 (August 1994), 1697 1706

  56. E. Neumann, M. Schaefer-Ridder, Y. Wang, P. H. Hofschneider, 1982 Gene transfer into mouse lyoma cells by electroporation in high electric fields, EMBO, 1 7 841 845

  57. S. Ohshima, J. H. Shin, K. Yuasa, A. Nishiyama, J. Kira, T. Okada, S. Takeda, 2009 Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle, Mol Ther, 17 1 (Jauary 2009), 73 80

  58. A. K. Patnaik, W. Y. Ehler, Ewen. E. G. Mac, 1984 Canine cutaneous mast cell tumors: morphological grading and survival in 83 dogs, Vet Pathol, 21 5 (september 1984), 469 474

  59. D. Pavlin, N. Tozon, G. Sersa, A. Pogacnik, M. Cemazar, 2008 Efficient electrotransfection into canine muscle, Technol Cancer Res Treat, 7 1 (February 2008), 45 54

  60. D. Pavlin, M. Cemazar, U. Kamensek, N. Tozon, A. Pogacnik, G. Sersa, 2009 Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma, Cancer Biol Ther, 8 22 (November 2009), 2114 2122

  61. D. Pavlin, M. Cemazar, A. Cor, G. Sersa, A. Pogacnik, N. Tozon, 2011 Electrogene therapy with interleukin-12 in canine mast cell tumors, Radiol Oncol, 45 1 (March 2011), 31 39

  62. B. S. Phillips, M. L. Padilla, E. B. Dickerson, M. J. Lindstrom, S. C. Helfand, 1999 Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs, Vet Immunol Immunopathol, 70 3-4 , (September 1999), 189 201

  63. C. J. Ross, J. Twisk, A. C. Bakker, F. Miao, D. Verbart, J. Rip, T. Godbey, P. Dijkhuizen, W. T. Hermens, J. J. Kastelein, J. A. Kuivenhoven, J. M. Meulenberg, M. R. Hayden, 2006 Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation, Hum Gene Ther, 17 5 (May 2006), 487 499

  64. K. M. Rassnick, Russell. Moore, N. C. Northrup, O. Kristal, D. B. Bailey, A. B. Flory, Intile. J. L. Kiselow, I. I. Phase, trial. open-label, single-agent. C. C. N. U. of, dogs. in, previously. with, histiocytic. untreated, J. sarcoma, Intern. Vet, , 24 24 6 (November 2010), 1528 1531

  65. B. Ryffel, 1996 Unanticipated human toxicology of recombinant proteins, Arch Toxicol Suppl, 18 333 341

  66. G. T. Selvarajah, J. Kirpensteijn, M. E. van Wolferen, N. A. Rao, H. Fieten, J. A. Mol, 2009 Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times, Molecular Cancer, 8 (September 2009), 72

  67. G. Sersa, B. Stabuc, M. Cemazar, D. Miklavcic, Z. Rudolf, 2000 Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients, Clin Canc Res, 6 3 (March 2000), 863 867

  68. F. Siddiqui, C. Y. Li, S. M. Larue, J. M. Poulson, P. R. Avery, A. F. Pruitt, X. Zhang, R. L. Ullrich, D. E. Thrall, M. W. Dewhirst, M. L. Hauck, 2007 A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas, Mol Cancer Ther, 6 1 (January 2007), 380 389

  69. K. A. Skorupski, C. C. Clifford, M. C. Paoloni, A. Lara-Garcia, L. Barber, M. S. Kent, A. K. Le Blanc, A. Sabhlok, E. A. Mauldin, F. S. Shofer, C. G. Couto, K. U. Sørenmo, 2007 CCNU for the treatment of dogs with histiocytic sarcoma, J Vet Intern Med, 21 1 (January 2007), 121 126

  70. M. M. Sleeper, L. T. Bish, H. L. Sweeney, 2010 Status of therapeutic gene transfer to treat canine dilated cardiomyopathy in dogs, Vet Clin North Am Small Anim Pract, 40 4 (July 2010), 717 724

  71. G. Tevz, S. Kranjc, M. Cemazar, U. Kamensek, A. Coer, M. Krzan, S. Vidic, D. Pavlin, G. Sersa, 2009 Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas, J Gene Med, 11 12 (December 2009), 1125 1137

  72. D. H. Thamm, D. M. Vail, 2007 Mast Cell Tumors, In: Withrow and MacEwen’s small animal clinical oncology, Withrow, S.J. & Wail, D.M., eds., 402 416 , Saunders, St. Louis, 978-0-72160-558-6

  73. S. Tollefsen, M. Vordermeier, I. Olsen, A. K. Storset, L. J. Reitan, D. Clifford, D. B. Lowrie, H. G. Wiker, K. Huygen, G. Hewinson, I. Mathiesen, T. E. Tjelle, 2003 DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants, Scand J Immunol, 57 3 (March 2003), 229 238

  74. C. M. Tone, D. M. Cardoza, R. H. Carpenter, R. Draghia-Akli, 2004 Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs, Cancer Gene Ther, 11 5 (May 2004), 389 396

  75. N. Tozon, G. Sersa, M. Cemazar, 2001 Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats, Anticancer Res, 21 4A (July 2001), 2483 2488

  76. N. Tozon, V. Kodre, G. Sersa, M. Cemazar, 2005 Effective treatment of perianal tumors in dogs with electrochemotherapy, Anticancer Res, 25 2A (March 2005), 839 845

  77. G. Trinchieri, M. Wysocka, A. D’Andrea, M. Rengaraju, M. Aste-Amezaga, M. Kubin, N. M. Valiante, J. Chehimi, 1992 Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation, Prog Growth Factor Res, 4 4 355 368

  78. G. Trinchieri, Interleukin-, regulation. the, innate. of, resistance, immunity. adaptive, Rev. Nat, Immunol, 3 3 2 (February 2003), 133 146

  79. E. E. Voest, B. M. Kenyon, M. S. O’Reilly, G. Truitt, R. J. D’Amato, J. Folkman, 1995 Inhibition of angiogenesis in vivo by interleukin 12, J Natl Cancer Inst, 87 8 (April 1995), 581 586

  80. M. C. Walker, T. C. Mandell, P. C. Crawford, G. G. Simon, K. S. Cahill, P. J. Fernandes, Leod. J. N. Mac, B. J. Byrne, J. K. Levy, 2005 Expression of erythropoietin in cats treated with a recombinant adeno-associated viral vector, Am J Vet Res, 66 3 (March 2005), 450 456

  81. L. Wang, R. W. Herzog, 2005 AAV-mediated gene transfer for treatment of hemophilia, Curr Gene Ther, 5 3 (June 2005), 349 360

  82. Z. Wang, C. S. Kuhr, J. M. Allen, M. Blankinship, P. Gregorevic, J. S. Chamberlain, S. J. Tapscott, R. Storb, 2007 Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression, Mol Ther, 15 6 (June 2007), 1160 1166

  83. Z. Wang, J. S. Chamberlain, S. J. Tapscott, R. Storb, 2009 Gene therapy in large animal models of muscular dystrophy, ILAR J, 50 2 187 198

  84. J. A. Wolff, R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, P. L. Felgner, 1990 Direct gene transfer into mouse muscle in vivo, Science, 247 (March 1990), 1465 1468

  85. S. Zhu, S. Li, 2008 Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation, Methods Mol Biol, 423 327 337